A detailed history of Nuveen Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 8,976,123 shares of BMY stock, worth $520 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
8,976,123
Previous 5,541,941 61.97%
Holding current value
$520 Million
Previous $230 Million 101.83%
% of portfolio
0.13%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $136 Million - $178 Million
3,434,182 Added 61.97%
8,976,123 $465 Million
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $177 Million - $234 Million
-4,407,780 Reduced 44.3%
5,541,941 $230 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $36.3 Million - $41.1 Million
-756,035 Reduced 7.06%
9,949,721 $540 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $31.2 Million - $37.3 Million
-644,574 Reduced 5.68%
10,705,756 $549 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $211 Million - $236 Million
-3,653,431 Reduced 24.35%
11,350,330 $659 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $84.7 Million - $94.1 Million
-1,330,078 Reduced 8.14%
15,003,761 $959 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $82.6 Million - $93.7 Million
-1,257,704 Reduced 7.15%
16,333,839 $1.13 Billion
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $66.4 Million - $78.6 Million
968,998 Added 5.83%
17,591,543 $1.27 Billion
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $112,456 - $66.5 Million
865,053 Added 5.49%
16,622,545 $1.18 Billion
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $162 Million - $178 Million
2,226,874 Added 16.46%
15,757,492 $1.21 Billion
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $25.2 Million - $30.2 Million
410,317 Added 3.13%
13,530,618 $961 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $47.5 Million - $55.3 Million
-884,926 Reduced 6.32%
13,120,301 $818 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $42.8 Million - $50.2 Million
-723,903 Reduced 4.91%
14,005,227 $829 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $20.4 Million - $22.2 Million
328,973 Added 2.28%
14,729,130 $984 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $9.37 Million - $10.5 Million
-157,862 Reduced 1.08%
14,400,157 $909 Million
Q4 2020

May 17, 2021

SELL
$57.74 - $65.43 $11 Million - $12.4 Million
-190,204 Reduced 1.29%
14,558,019 $903 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $89.8 Million - $102 Million
1,555,898 Added 11.79%
14,748,223 $915 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $1.98 Million - $2.2 Million
-34,499 Reduced 0.26%
13,192,325 $795 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $274 Million - $320 Million
-4,992,608 Reduced 27.4%
13,226,824 $778 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $143 Million - $208 Million
-3,091,390 Reduced 14.51%
18,219,432 $1.02 Billion
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $557 Million - $727 Million
11,327,720 Added 113.47%
21,310,822 $1.37 Billion
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $25.1 Million - $29.8 Million
587,982 Added 6.26%
9,983,102 $506 Million
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $416 Million - $460 Million
9,332,319 Added 14860.14%
9,395,120 $426 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $363,622 - $433,574
8,059 Added 14.72%
62,801 $3 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $8,874 - $11,507
182 Added 0.33%
54,742 $2.85 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $76,990 - $86,838
-1,395 Reduced 2.49%
54,560 $3.39 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $2.07 Million - $2.58 Million
-40,922 Reduced 42.24%
55,955 $3.1 Million
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $9.42 Million - $10.8 Million
-157,239 Reduced 61.88%
96,877 $6.13 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $11.5 Million - $12.5 Million
191,370 Added 304.99%
254,116 $0
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $3.47 Million - $4 Million
62,746
62,746 $4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.